MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
Clinical trials for MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA trials appear
Sign up with your email to follow new studies for MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo aims to tame rare lymphoma with less radiation
Disease control OngoingThis study tests a two-step treatment for people with early-stage MALT lymphoma, a slow-growing cancer of the lymph nodes. First, patients take a targeted drug called orelabrutinib. Then, based on how well the tumor responds, they receive an ultra-low dose of radiation (4Gy) to a…
Matched conditions: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Tiny radiation dose may tame eye lymphoma
Disease control OngoingThis study tests whether a very low dose of radiation (4 Gy) can control slow-growing B-cell lymphoma in the eye socket. About 50 adults with stage I-IV indolent lymphoma or mantle cell lymphoma will receive this targeted treatment. The goal is to shrink or stop the cancer while …
Matched conditions: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC